Bausch & Lomb Corp
BLCO- Exchange
- NYSE
- Industry
- Ophthalmic Goods
- SEC CIK
- 0001860742
In the last 90 days, Bausch & Lomb Corp insiders filed 0 open-market purchases and 2 sales; 99 institutions reported holding it in 13F filings for Q2 2026, worth $638.7M in total; 3 superinvestors hold it, including Icahn Capital and Oaktree Capital.
Holders of 5% or more of BLCO
Holders whose latest Schedule 13D or 13G filing reports 5% or more of Bausch & Lomb Corp, largest stake first. The change is against the holder's previous filing.
No holder currently reports owning 5% or more of Bausch & Lomb Corp on Schedule 13D or 13G.
Stakes are as of each holder's latest filing. Holders whose last filing was in the old format (before December 18, 2024) have no stake on record and are not listed, and after an acquisition or delisting holders usually stop filing.
13D and 13G filings
Schedule 13D and 13G filings on Bausch & Lomb Corp, newest first.
No Schedule 13D or 13G filings on Bausch & Lomb Corp are on file.
Form 144: proposed insider sales
Notices from officers, directors and other affiliates planning to sell Bausch & Lomb Corp shares.
No Form 144 notices for Bausch & Lomb Corp are on file.